Latest From David Ridley
Over The Counter 20 Feb 2024: AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite
The Association of the European Self-Care Industry celebrates its 60th birthday this year. In this episode, we catch up with AESGP director general, Jurate Švarcaite, to find out how the association will mark the occasion, including at this year’s Annual Meeting in Brussels in June. AESGP Annual Meetings are an excellent way to find out what the key issues and trends are impacting the European consumer health industry, and this one will be no different. We talk through some of the key themes of this year’s conference. Sustainability continues to be a mega-trend, closely followed by digitalization and artificial intelligence. With its wide-ranging footprint across OTC medicines, food supplements and self-care medical devices sectors, the consumer health industry is facing an avalanche of regulations, and the AESGP continues to be an effective advocate for its stakeholders, alongside adjacent industry partners.
The EU Green Deal brings with it numerous directives, strategies and frameworks which consumer health companies operating in the region must work out how to navigate. To assist companies facing this regulatory storm, HBW Insight has produced an infographic which brings together in one place the main EU legislation supporting the Green Deal.
Almost half of European respondents to a Kenvue-commissioned survey said they had chosen to visit a pharmacist rather than a doctor for advice about minor ailments in the last year, even though a consultation was necessary from their point of view.
Botanical extracts power new products from P&G Health and Théa Pharmaceuticals in the areas of pain and eye-care respectively, while TheOTCLab and Stada relaunch much-loved foot care and cold brands in this German OTC marketing update.
The EU's revised Urban Wastewater Treatment Directive is one step closer to implementation thanks to provisional agreement between the European Parliament and Council. In line with the “polluter pays” principle, producers of pharmaceuticals and cosmetics should contribute at least 80% towards the costs of removing micropollutants from wastewater through quaternary treatment, the legislative bodies agree.
UK doctors are calling for the reclassification of oral emergency hormonal contraceptives (EHCs) from pharmacy (P) medicine status to general sales list (GSL) status in the country. Manufacturer Maxwellia, which markets levonorgestrel-based emergency contraception, LoviOne, says it "has what it takes to get this over the line" with the UK Medicines and Healthcare products Regulatory Agency.